A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Volume 26, 2022 Articles
Title/Author (Click for Abstract / Details / Purchase)	Issue/​Page View/Buy
PreScription: IJPC--Starting Year 26 Allen Loyd V Jr	Jan/Feb 2022 Pg. 4
Compounded Melatonin Cream for the Prevention and Treatment of Radiation Dermatitis: A Case Report Garcia-Segura Laura Corral, Garcia-Segura Javier Corral, Delgado Carlos Dorado, Maldonaldo Nuria Romero, Salgado Elena Cardero, Llorens Lucía Pérez	Jan/Feb 2022 Pg. 6-8
Pharmacy Student Satisfaction and Perceptions Following a Virtual Sterile Compounding Experience Mohammad Insaf, Lobkovich Alison, Nardolillo Joseph, Wilhelm Shelia	Jan/Feb 2022 Pg. 10-17
A Compendium of Compounding Agents and Formulations, Part 1: Melatonin Riepl Mike	Jan/Feb 2022 Pg. 18-23
Editorial: Should All Pharmacists Compound? Allen Loyd V Jr	Jan/Feb 2022 Pg. 24-28
Everything Old is New Again Brunner Scott	Jan/Feb 2022 Pg. 30-32
Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories Allen Loyd V Jr	Jan/Feb 2022 Pg. 34-38
Sterile Basics: Compounding Sterile Preparations with Cyclodextrins Allen Loyd V Jr	Jan/Feb 2022 Pg. 41-49
Calculations Stockton Shelly J	Jan/Feb 2022 Pg. 50
Aluminum Chloride 6.25% in Anhydrous Alcohol Allen Loyd V Jr	Jan/Feb 2022 Pg. 52
Ascorbic Acid 10% in Anhydrous PEG ointment Allen Loyd V Jr	Jan/Feb 2022 Pg. 53
Deoxyarbutin 3% Anhydrous Emulsion Allen Loyd V Jr	Jan/Feb 2022 Pg. 54
Diclofenac Sodium 1%-15% Topical Gel Allen Loyd V Jr	Jan/Feb 2022 Pg. 55
Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension Allen Loyd V Jr	Jan/Feb 2022 Pg. 56
Mometasone Furoate 0.1% Lotion Allen Loyd V Jr	Jan/Feb 2022 Pg. 57
Capsule Machine Validation Al-Achi Antoine, McGreggor Tysheon, Jaligama Shreelekha, Friday Kafi, Alyami Hussain	Jan/Feb 2022 Pg. 58-64
Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management Hong Eun Ji, Sumanasekera Wasana, Le Uyen Minh	Jan/Feb 2022 Pg. 65-71
Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint) Soefje Scott, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P	Jan/Feb 2022 Pg. 72-79
Investigation of the Effects of Excipients in the Compounding of Amlodipine Besylate Orally Disintegrating Tablets Azmi Nurual Hanisah Saiful, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai	Jan/Feb 2022 Pg. 80-87
PreScription: Comments on the FDA Guidance "Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry" Allen Loyd V Jr	Mar/Apr 2022 Pg. 92
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin Riepl Mike	Mar/Apr 2022 Pg. 94-98
Allowing Compounding Pharmacies to Address Drug Shortages Broughel James	Mar/Apr 2022 Pg. 100-109
The Potential Effects of a Compounded Methylcobalamin Nasal Spray on Short-term Memory Loss After Intracranial Hemorrhage: A Case Report Good Lauren, Lieu Yi, Banov Fabiana, Harger Beau, Banov Daniel	Mar/Apr 2022 Pg. 110-115
Quality Control: Photodocumentation in Pharmacy Compounding Allen Loyd V Jr	Mar/Apr 2022 Pg. 116-117
Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins Allen Loyd V Jr	Mar/Apr 2022 Pg. 118-126
Sterile Basics of Compounding: Methods of Sterilization and Depyrogenation Allen Loyd V Jr	Mar/Apr 2022 Pg. 129-136
Calculations Stockton Shelly J	Mar/Apr 2022 Pg. 138
Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2022 Pg. 140
Codeine Phosphate 3 mg/mL in Ora-Sweet Allen Loyd V Jr	Mar/Apr 2022 Pg. 141
Ketoconazole 2%, Terbenafine 1%, Acetic Acid 2%, and Urea 2% in Dimethyl Sulfoxide Nail Polish Allen Loyd V Jr	Mar/Apr 2022 Pg. 142
Lorazepam 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2022 Pg. 143
Mesalamine 100-mg/mL Suspension Enema Allen Loyd V Jr	Mar/Apr 2022 Pg. 144
Naproxen 25 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2022 Pg. 145
Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored Allen Loyd V Jr	Mar/Apr 2022 Pg. 146
Phenytoin 15 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2022 Pg. 147
Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension Allen Loyd V Jr	Mar/Apr 2022 Pg. 148
Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2022 Pg. 149
Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates) Brandin Thibaut, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice	Mar/Apr 2022 Pg. 150-154
Comparison of Solvent Casting and Spray Casting Method on Compounding of an Orally Disintegrating Film Containing Amlodipine Besylate Ruslan Mohamad Fariz Haiqal, Janakiraman Ashok Kumar, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai	Mar/Apr 2022 Pg. 155-162
Molding as Innovative Technology for Personalized Tablet Production Mady Omar Y, Al-Shoubki Adam A, Hagag Youssef, Ibrahim Bakry, Donia Ahmed A	Mar/Apr 2022 Pg. 163-174
PreScription: Standing in the Gap Allen Loyd V Jr	May/Jun 2022 Pg. 180
Art of Pharmacy v. State Standridge Rob	May/Jun 2022 Pg. 182-186
A Compendium of Compounding Agents and Formulations, Part 3: Gentamicin Sulfate and Benzoyl Peroxide Riepl Mike	May/Jun 2022 Pg. 189-193
A Procedure for Tablet Production by Using the 3D Molding Technology and Powder Micromeritics Properties Mady Omar	May/Jun 2022 Pg. 195-200
Compounding for Investigational and Clinical Studies Allen Loyd V Jr	May/Jun 2022 Pg. 201-209
Three Things You Need to Know Right Now Brunner Scott	May/Jun 2022 Pg. 211-213
Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes Allen Loyd V Jr	May/Jun 2022 Pg. 214-217
Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection Allen Loyd V Jr	May/Jun 2022 Pg. 219-228
Calculations Stockton Shelly J	May/Jun 2022 Pg. 230
Alendronate Sodium 1% Topical Dental Gel Allen Loyd V Jr	May/Jun 2022 Pg. 232
Azstarys in Ora-Blend Single Dose Allen Loyd V Jr	May/Jun 2022 Pg. 233
Candesartan Cilexitil 1 mg/mL Syrup Allen Loyd V Jr	May/Jun 2022 Pg. 234
Chloral Hydrate 70 mg/mL Syrup Allen Loyd V Jr	May/Jun 2022 Pg. 235
Cinnarizine 1 mg/mL in Oral Medium-Chain Triglycerides Anhydrous Vehicle Allen Loyd V Jr	May/Jun 2022 Pg. 236
Clobazam 1 mg/mL in Oral-Mix Suspension Allen Loyd V Jr	May/Jun 2022 Pg. 237
Metronidazole 7.5 mg/mL Topical Oil-in-Water Microemulsion Allen Loyd V Jr	May/Jun 2022 Pg. 238
Nitrazepam 1 mg/mL Oral Solution Allen Loyd V Jr	May/Jun 2022 Pg. 239
Sirolimus 0.1% Ointment Allen Loyd V Jr	May/Jun 2022 Pg. 240
Valganciclovir 20 mg/mL in Ora-Plus and Ora-Sweet Suspension Allen Loyd V Jr	May/Jun 2022 Pg. 241
Finding the Right Balance: A Nationwide Study of Student Pharmacist Exposure to and Perceptions of Nonsterile Compounding Fredrickson Mary E, Belcher Faith G, Del Vecchio Kamryn N, Galleher Miranda N, Jugo Leila S, Gothard M David, Pallotta Raneem H, Pallotta Victor A Jr	May/Jun 2022 Pg. 242-247
Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine Catry Emilie, Colsoul Marie-Louise, Closset Melanie, Hubert Justine, Soumoy Laura, Bihin Benoit, Thiry Emmanuell, Jamart Jacques, Hecq Jean-Daniel, Galanti Laurence	May/Jun 2022 Pg. 248-254
Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets Liew Kai Bin, Hii Shou Hui, Chew Yik Ling, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam	May/Jun 2022 Pg. 255-263
PreScription: Pharmacy and Drug Information Allen Loyd V Jr	Jul/Aug 2022 Pg. 268
A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline Riepl Mike	Jul/Aug 2022 Pg. 270-274
Compounding with Pracaxi Versus Copaiba Oil Magutu Tom	Jul/Aug 2022 Pg. 277-281
Evaluation of the Physical-chemical Characteristics and Biopharmaceutical Performance of Dilu-Cap: A Complete Line of Excipients for Hard-shell Capsules de Oliveira Ferreira Anderson, Polonini Hudson	Jul/Aug 2022 Pg. 283-291
Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases Harrington Amy, Williams LaVonn	Jul/Aug 2022 Pg. 293-296
The Role of Compounding Pharmacists During Drug Shortages Ofei Kelvin	Jul/Aug 2022 Pg. 298-301
Basics: Hollow-type Suppositories Allen Loyd V Jr	Jul/Aug 2022 Pg. 302-307
Sterile Basics of Compounding: How to Implement a Robust Visual-inspection Program Summers Amy	Jul/Aug 2022 Pg. 309-315
Calculations Stockton Shelly J	Jul/Aug 2022 Pg. 316
Betamethasone Dipropionate 0.05% and Salicylic Acid 3% Lotion Allen Loyd V Jr	Jul/Aug 2022 Pg. 318
Cetrimide Lotion Allen Loyd V Jr	Jul/Aug 2022 Pg. 319
Dexamethasone 1 mg/mL in Oral Mix Allen Loyd V Jr	Jul/Aug 2022 Pg. 320
Furosemide 5-mg/mL Oral Suspension Allen Loyd V Jr	Jul/Aug 2022 Pg. 321-322
Hydralazine Hydrochloride 10 mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2022 Pg. 323-324
Indomethacin 1% Topical Gel Allen Loyd V Jr	Jul/Aug 2022 Pg. 325-326
Nystatin 250,000-unit Frozen Popsicles Allen Loyd V Jr	Jul/Aug 2022 Pg. 327
Povidone Iodine 100-mg/mL Solution/Spray Allen Loyd V Jr	Jul/Aug 2022 Pg. 328
Psoriasis Topical Ointment Allen Loyd V Jr	Jul/Aug 2022 Pg. 329
Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes Bartoll Aaron Puplà, Bellés Medall Maria Dolores, Peñarrocha Josep Edo, Escrig Laura Solaz, Clemente Ruben Eguren, Azuara Julia Bodega, Piqueres Raul Ferrando	Jul/Aug 2022 Pg. 330-335
Long-term Stability of Epitheliotropic Factors in Frozen Serum Eye Drops Sahyoun Jean-Yves, Cloutier Marc, Frenette Mathieu, Robert Marie-Claude	Jul/Aug 2022 Pg. 336-341
Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A	Jul/Aug 2022 Pg. 342-351
PreScription: A New Dosage Form Allen Loyd V Jr	Sep/Oct 2022 Pg. 356
Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration Lopez C Vidal, Rios GL Quito	Sep/Oct 2022 Pg. 358-362
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans Riepl Mike	Sep/Oct 2022 Pg. 364-368
Recent Formulation Advances and Preparation of Orally Disintegrating Tablets Ejeta Fikadu	Sep/Oct 2022 Pg. 370-377
Compounded Medications and Probiotics for Irritable Bowel Syndrome Narváez Katherine Rivera, Thompson Tara	Sep/Oct 2022 Pg. 378-384
Compounding with Biotechnology Products, Part 1: General Considerations Allen Loyd V Jr	Sep/Oct 2022 Pg. 385-395
The FDA is in a Hole. It Should Stop Digging. Brunner Scott	Sep/Oct 2022 Pg. 396-398
Basics of Compounding: Compounding with Microneedle Arrays, Part 1: Introduction and Overview Allen Loyd V Jr	Sep/Oct 2022 Pg. 400-408
Sterile Basics of Compounding: Contamination Control Strategies, Part 1 Summers Amy	Sep/Oct 2022 Pg. 411-418
Calculations Stockton Shelly J	Sep/Oct 2022 Pg. 420
Amphotericin B 3% Otic Gel Allen Loyd V Jr	Sep/Oct 2022 Pg. 422
Ascorbic acid 5% Topical Microemulsion Allen Loyd V Jr	Sep/Oct 2022 Pg. 423
Chlorhexidine Diacetate 2% Topical Gel Allen Loyd V Jr	Sep/Oct 2022 Pg. 424
Clindamycin Hydrochloride 10-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2022 Pg. 425
Clotrimazole 10-mg Troches Allen Loyd V Jr	Sep/Oct 2022 Pg. 426
Cysteamine Hydrochloride 100 mg/mL Oral Solution Allen Loyd V Jr	Sep/Oct 2022 Pg. 427
Hydrogen Peroxide 1.5% with Sodium Fluoride 0.5-mg/mL Oral Rinse Allen Loyd V Jr	Sep/Oct 2022 Pg. 428
Lansoprazole 3-mg/mL in Ora-Blend Suspension Allen Loyd V Jr	Sep/Oct 2022 Pg. 429
Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment Allen Loyd V Jr	Sep/Oct 2022 Pg. 430
Methylcobalamin 2-mg/mL Nasal Spray Allen Loyd V Jr	Sep/Oct 2022 Pg. 431
Effectiveness of a New Ultraviolet C Disinfection System to Inactivate Airborne Coronavirus in Different Environmental Conditions Marianni Bruna, Polonini Hudson	Sep/Oct 2022 Pg. 432-435
Effects of Calcium Polystyrene Sulfonate Formulation Change from Dry Syrup to Oral Solution in Patients with Chronic Kidney Disease Kobayashi Shunsuke, Ogawara Yuka, Imamura Yoshihiko, Kitaoka Akira, Yasu Takeo	Sep/Oct 2022 Pg. 436-439
PreScription: Compounded Drugs Often Become Manufactured Drugs Allen Loyd V Jr	Nov/Dec 2022 Pg. 444
Compounding with Biotechnology Products, Part 2: Product-specific Considerations Allen Loyd V Jr	Nov/Dec 2022 Pg. 446-466
Unlicensed Transdermal Medications in Feline Patients: Three Case Reports Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael	Nov/Dec 2022 Pg. 468-472
Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies Maham Nicole Y	Nov/Dec 2022 Pg. 474-479
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing Riepl Mike	Nov/Dec 2022 Pg. 480-488
Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods Allen Loyd V Jr	Nov/Dec 2022 Pg. 490-495
Sterile Basics of Compounding: Contamination Control Strategies, Part 2 Summers Amy	Nov/Dec 2022 Pg. 497-504
Calculations Stockton Shelly J	Nov/Dec 2022 Pg. 506
Bacitracin 0.01% and Phenol 0.1% in Cetaphil Lotion Allen Loyd V Jr	Nov/Dec 2022 Pg. 508
Curcumin 2% Topical Gel Allen Loyd V Jr	Nov/Dec 2022 Pg. 509
Diazoxide 10-mg/mL in Oral Mix SF Allen Loyd V Jr	Nov/Dec 2022 Pg. 510
Enrofloxacin 11.35 mg/mL in Ora-Blend, Veterinary Allen Loyd V Jr	Nov/Dec 2022 Pg. 511
Flucytosine 50 mg/mL in Oral-Sweet and Ora-Plus Allen Loyd V Jr	Nov/Dec 2022 Pg. 512
Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus Allen Loyd V Jr	Nov/Dec 2022 Pg. 513
Miller's Modified Mouthwash Allen Loyd V Jr	Nov/Dec 2022 Pg. 514
Potassium Alum 1% Bladder Irrigation for Hemorrhagic Cystitis (Low-Medium Risk Compounding) Allen Loyd V Jr	Nov/Dec 2022 Pg. 515
Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage Kumaravelrajan Rajagopal, Karthik B, Venkatasan Suba	Nov/Dec 2022 Pg. 516-521
Intravenous Physical Compatibility of Heparin Sodium and Furosemide Maktabi Briana, Howard Mitchell S, Baki Gabriella, Churchwell Mariann D	Nov/Dec 2022 Pg. 522-526
Return to Top